Novo Nordisk remains a dominant business with a strong pipeline, and current multiples are low enough to justify a buy. Read my latest analysis of NVO stock.

Late Thursday, New York-based Warburg announced an agreement to buy ECN, run by entrepreneur and chief executive officer ...

Atlanta Hawks forward Jalen Johnson made history on Thursday night, posting a stat line that has never been seen before in ...

Thank you, Paul. The continued momentum in both our U.S. and international businesses during Q3 saw over 14 million average ...